Shuhang Wang

Associate Chief Physician

Chinese Academy of Medical Sciences Cancer Hospital

Short Biography

Wang Shuhang, Doctor of Medicine (PhD), Associate Chief Physician, graduated from Peking University. He is a postdoctoral fellow at Roswell Park Cancer Institute&Mayo Clinic, GCP Center, Chinese Academy of Medical Sciences Cancer Hospital. He is a drug clinical trial inspector at the National Medical Products Administration, a member of the Clinical Research Professional Committee of the Beijing Cancer Society, a member of the Clinical Expert Committee of the Beijing Health Promotion Association, a member of the Tumor Marker Professional Committee of the China Anti Cancer Association, and an editorial board member of the Journal of Thoracic Oncology. Committed to clinical research and translational research of anti-tumor new drugs, including the development of cellular genes, tumor vaccines, small and large molecules and their delivery platforms, specializing in personalized targeted and immunotherapy for rare tumors and lung cancer, as well as multidisciplinary comprehensive treatment for advanced solid tumors. Focusing on the mechanism research of anti-tumor drugs, as well as the study of tumor heterogeneity and immune microenvironment. Published over 80 articles as the first or responsible author in internationally renowned oncology journals such as JAMA, Cancer Cell, JAMA Oncology, Cancer Discovery, and JTO, with a total impact factor of over 720 points. Participated in the compilation of 2 textbooks and led the writing of 4 guidelines for cancer diagnosis and treatment. Hosted or participated in the construction of the Clinical Trial Capability Enhancement (GCP) platform, National Natural Science Foundation of China Youth and General Projects, National Key R&D Program, Beijing Municipal Health Commission Science and Technology Commission and other provincial and ministerial level projects, clinical translational research projects, ASCO LIFE Grant and other projects. Journal of Clinical Oncology, Journal of Thoracic Oncology, Journal of Hematology and Oncology, Lung Cancer Waiting for senior reviewers of international oncology journals.

Presentation Topic: NCCGCP肿瘤创新药蛋白靶点平台